title: Adult Urological Soft Tissue Sarcomas: A Multicenter Study of the Anatolian Society of Medical Oncology (ASMO).
abstract: OBJECTIVE
  To analyze clinicopathological characteristics, prognostic factors and survival rates of the patients with urological soft tissue sarcomas treated and followed up in Turkey.
  
  
  METHODS
  For overall survival analyses the Kaplan-Meier method was used. From medical records, nine prognostic factors on overall survival were analysed.
  
  
  RESULTS
  For the 53 patients (34 males, 19 females) whose charts were reviewed, the median age was 53 (range 22 to 83) years. Most frequently renal location (n=30; 56.6%) was evident and leiomyosarcoma (n=20, 37.7%) was the most frequently encountered histological type. Median survival time of all patients was 40.3 (95% CI, 14.2-66.3) months. In univariate analysis, male gender, advanced age (≥50 years), metastatic stage, unresectability, grade 3, renal location were determined as worse prognostic factors. In multivariate analysis, metastatic stage, unresectability and grade 3 were determined as indicators of worse prognosis.
  
  
  CONCLUSIONS
  Urological soft tissue sarcomas are rarely seen tumours in adults. The most important factors in survival are surgical resection, stage of the tumour at onset, grade and location of the tumour, gender and age of the patients.
authors.affiliation: Division of Medical Oncology, Department of Internal Medicine, Dokuz Eylul University Medical Faculty, Izmir, Turkey E-mail : drolcun@hotmail.com.
authors.forename: Olcun Umit
authors.initials: OU
authors.lastname: Unal
authors.forename: Ilhan
authors.initials: I
authors.lastname: Oztop
authors.forename: Serkan
authors.initials: S
authors.lastname: Menekse
authors.forename: Zuhat
authors.initials: Z
authors.lastname: Urakci
authors.forename: Oktay
authors.initials: O
authors.lastname: Bozkurt
authors.forename: Melke
authors.initials: M
authors.lastname: Ozcelik
authors.forename: Yusuf
authors.initials: Y
authors.lastname: Gunaydin
authors.forename: Nurgul
authors.initials: N
authors.lastname: Yasar
authors.forename: Dogan
authors.initials: D
authors.lastname: Yazilitas
authors.forename: Hilmi
authors.initials: H
authors.lastname: Kodaz
authors.forename: Burcu Yapar
authors.initials: BY
authors.lastname: Taskoylu
authors.forename: Asude
authors.initials: A
authors.lastname: Aksoy
authors.forename: Umut
authors.initials: U
authors.lastname: Demirci
authors.forename: Murat
authors.initials: M
authors.lastname: Araz
authors.forename: Onder
authors.initials: O
authors.lastname: Tonyali
authors.forename: Alper
authors.initials: A
authors.lastname: Sevinc
authors.forename: Ahmet Ugur
authors.initials: AU
authors.lastname: Yilmaz
authors.forename: Mustafa
authors.initials: M
authors.lastname: Benekli
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D060787:Neoplasm Grading; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D011379:Prognosis; D012509:Sarcoma / Q000401:mortality* / Q000473:pathology* / Q000601:surgery; D015996:Survival Rate; D014571:Urologic Neoplasms / Q000401:mortality* / Q000473:pathology* / Q000601:surgery; D055815:Young Adult